Literature DB >> 8635227

Cellular basis for the negative dromotropic effect of adenosine on rabbit single atrioventricular nodal cells.

D Wang1, J C Shryock, L Belardinelli.   

Abstract

The effects of adenosine on action potentials, rate-dependent activation failure (the cellular basis for second-degree atrioventricular [AV] block), and the recovery of excitability in rabbit isolated single AV nodal cells were studied using the whole-cell patch-clamp technique. Adenosine (1 micromol/L) shortened the duration, depressed the amplitude, and reduced the rate of rise of the AV nodal cell action potential. Adenosine (10 micromol/L) caused a significant hyperpolarization (7 +/- 1 mV) of AV nodal cells. Adenosine increased the occurrence and the rate dependence of activation failure (Wenckebach periodicity) of AV nodal cells: this effect was concentration dependent and mediated by A1 adenosine receptors. The rate-dependent activation failure caused by adenosine was associated with a prolongation of the effective refractory period by 18 +/- 2 ms (P < .05), an increase in the duration of activation delay, and an elevation (from 0.22 +/- 0.04 to 0.30 +/- 0.03 nA, P < .05) of the threshold current amplitude required to activate AV nodal cells. The results suggest that the slowed recovery of excitability of AV nodal cells caused by adenosine forms the cellular basis for adenosine-induced second-degree AV block. Adenosine decreased ICa,L and activated IK,ADO of AV nodal cells. These actions of adenosine on ion currents may contribute to the effect of this nucleoside to depress excitability of AV nodal cells. The enhancement by adenosine of rate-dependent activation failure of AV nodal cells implies that the negative dromotropic effect of adenosine should be more pronounced during an episode of supraventricular tachycardia than during normal rhythm.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635227     DOI: 10.1161/01.res.78.4.697

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

1.  Imaging of adenosine bolus transit following intravenous administration: insights into antiarrhythmic efficacy.

Authors:  G A Ng; W Martin; A C Rankin
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 2.  Antiarrhythmics--from cell to clinic: past, present, and future.

Authors:  J C Hancox; K C Patel; J V Jones
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

Review 3.  Sinus arrest during adenosine stress testing in liver transplant recipients with graft failure: three case reports and a review of the literature.

Authors:  Kenneth N Giedd; Sabahat Bokhari; Teresa P Daniele; Lynne L Johnson
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

4.  Mediation by nitric oxide of the indirect effects of adenosine on calcium current in rabbit heart pacemaker cells.

Authors:  Y Shimoni; X Han; D Severson; W R Giles
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  [Mapping and ablation of a mechanically blocked concealed accessory pathway under repeated adenosine bolus infusions].

Authors:  Martin Huemer; Philipp Attanasio; Alexander Wutzler; Abdul Shokor Parwani; Leif-Hendrik Boldt; Wilhelm Haverkamp
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-08-12

6.  Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity.

Authors:  Nicholas Ellinwood; Dobromir Dobrev; Stefano Morotti; Eleonora Grandi
Journal:  Chaos       Date:  2017-09       Impact factor: 3.642

Review 7.  Adenosine and the Cardiovascular System.

Authors:  Allison B Reiss; David Grossfeld; Lora J Kasselman; Heather A Renna; Nicholas A Vernice; Wendy Drewes; Justin Konig; Steven E Carsons; Joshua DeLeon
Journal:  Am J Cardiovasc Drugs       Date:  2019-10       Impact factor: 3.571

8.  In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding.

Authors:  Nicholas Ellinwood; Dobromir Dobrev; Stefano Morotti; Eleonora Grandi
Journal:  Front Pharmacol       Date:  2017-11-07       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.